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Abstract
Background and Purpose: Recent evidence indicates an involvement of P2X7
purinergic receptor (P2X7R) in the fine tuning of immune functions, as well as in
driving enteric neuron apoptosis under intestinal inflammation. However, the
participation of this receptor in the regulation of enteric neuromuscular functions
remains undetermined. This study was aimed at investigating the role of P2X7Rs in
the control of colonic motility in experimental colitis.
Experimental Approach: Colitis was induced in rats by 2,4-dinitrobenzenesulfonic
acid. P2X7R distribution was examined by immunofluorescence analysis. The
effects of A804598 (selective P2X7R antagonist) and BzATP (P2X7R agonist) were
tested on contractions of longitudinal smooth muscle evoked by electrical
stimulation or by carbachol in the presence of tetrodotoxin.
Key Results: P2X7Rs were predominantly located in myenteric neurons, but, in the
presence of colitis, their expression increased in the neuromuscular layer. In normal
preparations, A804598 elicited a negligible increase in electrically induced
contractions, while a significant enhancement was recorded in inflamed tissues. In
the presence of Nv-propyl-L-arginine (NPA, neuronal nitric oxide synthase inhibitor)
the A804598 effects were lost. P2X7R stimulation with BzATP did not significantly
affect electrical-induced contractions in normal colon, while a marked reduction was
recorded under inflammation. The inhibitory effect of BzATP was antagonized by
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A804598, and it was also markedly blunted by NPA. Both P2X7R ligands did not
affect carbachol-induced contractions.
Conclusions and Implications: The purinergic system contributes to functional
neuromuscular changes associated with bowel inflammation via P2X7Rs, which
modulate the activity of excitatory cholinergic nerves through a facilitatory control
on inhibitory nitrergic pathways.
Introduction
Inflammatory bowel diseases (IBDs) include a wide spectrum of disorders,
characterized by chronic or relapsing immune activation and inflammation within
the gastrointestinal tract, followed by marked alterations of several digestive
functions [1]. These diseases display an exasperated immune response followed by
abnormal intestinal secretion with marked alterations in the patterns of motility
and visceral sensation, which all together lead to abdominal pain, cramping, fecal
urgency and/or constipation [2].
Although the pathogenic mechanisms underlying IBDs are scarcely character-
ized, available data suggests that redundant interactions between immune and
non-immune cells, such as neuronal and smooth muscle cells, are critical events
leading to relevant changes in the homeostasis and morphological features of the
enteric neuromuscular compartments [3]. However, most of the mechanisms,
through which intestinal inflammation affects the enteric neurotransmission and
bowel neuromuscular functions, remain scarcely understood.
Several lines of evidence support a pivotal role of purinergic signalling in the
physiological regulation of digestive functions [3] as well as in the modulation of
immune/inflammatory cell activity [4, 5]. Over the last years, increasing attention
has been focused on the purinergic P2X7 receptor, an ATP-gated Ca2+ and Na+
channel, characterized by low affinity for ATP, widely expressed on several
immune cells (macrophages, lymphocytes, and microglia) [6]. In particular, this
receptor, acting as a danger sensor in the immune system, regulates immune cell
proliferation, differentiation and death [7], participating also to the fine tuning of
several proinflammatory cytokine release [interleukin-1 b (IL-1b), interleukin-6
(IL-6), interleukin-18 (IL-18) and tumor necrosis factor (TNF)] [8, 9].
At present, despite evidence describing a physiological expression of P2X7
receptors in the colonic neuromuscular compartment [10], only studies, aimed at
investigating the significance of these receptors in the pathophysiology of
intestinal inflammation, have been performed. Recently, a pioneeristic study by
Gulbransen et al. [11] evaluated the involvement of neuronal P2X7 receptors in
neurodegeneration associated with experimental colitis. Interestingly, this work
demonstrated the significance of these receptors in mediating the process of
enteric neuronal death, through the activation of a complex signalling, including
also the pannexin-1 channel [11]. This interesting observation suggests a critical
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involvement of P2X7 receptors in neuronal rearrangement occurring in the
presence of bowel inflammation, thus encouraging the performance of functional
studies aimed at evaluating the possible involvement of these receptors in the
pathophysiology of intestinal motor dysfunctions. Based on this background, the
present study was designed to investigate the expression of P2X7 receptors in the
neuromuscular compartment of rat colon and to characterize their functional role
in the control of colonic motility in the presence of experimentally colitis.
Materials and Methods
Animals
Albino male Sprague-Dawley rats, 200–250 g body weight, were used throughout
the study. The animals were fed standard laboratory chow and tap water ad
libitum and were not employed for at least one week after their delivery to the
laboratory. They were housed, three in a cage, in temperature-controlled rooms
on a 12 h light cycle at 22–24 C˚ and 50–60% humidity. All experimental protocols
were approved by the Animal Care and Use Committee of the University of Pisa,
and were in compliance with the national and European guidelines for handling
and use of experimental animals.
Induction and assessment of colitis
Colitis was induced as described by Antonioli et al. [12]. Animals were
anaesthetized with isoflurane and 30 mg of 2,4-dinitrobenzenesulfonic acid
(DNBS) in 0.25 ml of 50% ethanol were administered intrarectally with a
polyethylene catheter inserted 8 cm proximal to the anus. Control animals
received 0.25 ml of vehicle. Animals underwent subsequent experimental
procedures 6 days after DNBS injection, in order to allow a full development of
histologically evident colonic inflammation. At that time, the animals were
euthanized by overdose of isoflurane, and the colon was excised and processed for
macroscopic damage score, recording of contractile activity, and histology, as
reported below. The evaluation of inflammation severity was performed both
macroscopically and histologically, in accordance with the criteria previously
reported by Antonioli et al. [13]. The macroscopic criteria were: presence of
adhesions between colon and other intra-abdominal organs; consistency of
colonic faecal material (indirect marker of diarrhoea); thickening of colonic wall;
presence and extension of hyperaemia and macroscopic mucosal damage
(assessed with the aid of a ruler). Microscopic evaluations were carried out by
light microscopy on haematoxylin- and eosin-stained sections obtained from
whole-gut specimens, taken from a region of inflamed colon immediately adjacent
to the gross macroscopic damage and fixed in cold 4% neutral formalin diluted in
phosphate-buffered saline (PBS). Histological criteria included: degree of mucosal
architecture changes; cellular infiltration; external muscle thickening; presence of
crypt abscess and goblet cell depletion. All parameters of macroscopic and
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histological damage were recorded and scored for each rat by two observers
blinded to the treatment.
Immunofluorescence
Immunofluorescence was performed on frozen distal colonic tissue embedded in
optimal cutting temperature mounting medium and sectioned (7 mm-thick) with
a cryostat-microtome, as previously described by Antonioli et al. [14]. Briefly,
colonic sections from control and DNBS-treated rats were fixed in 4%
paraformaldehyde and incubated with 0.05 M NH4Cl. After Tris-buffered saline
wash with 0.5% bovine serum albumin, samples were permeabilized with 0.3%
Triton X-100 and incubated with rabbit anti-P2X7 receptor-ATTO-488 (1:100;
Alomone labs, Jerusalem, Israel) and with either mouse biotin-labelled anti-HuC/
D (1:100; Molecular Probes, Eugene, OR, USA) or mouse monoclonal anti-glial
fibrillary acidic protein (GFAP, 1:800; Sigma-Aldrich, Milan, Italy) for 1 hour at
room temperature. To evaluate immune cell infiltration in the ENS, permeabilized
tissue sections were incubated with mouse biotin-labelled anti-HuC/D (1:100;
Molecular Probes, Eugene, OR, USA) and with either mouse monoclonal anti-
CD68 (1:100, Abcam, Cambridge, UK) or mouse monoclonal anti mast cell
tryptase (1:100 Abcam, Cambridge, UK) for 1 hour at room temperature.
Thereafter, sections were incubated with goat anti-mouse IgG (1:1000; Life
Technologies, Milan, Italy) labelled with Alexa Fluor 555 or Alexa Fluor 488, or
with streptavidin (1:1000, Life Technologies, Milan, Italy), labelled with and Alexa
Fluor 555. Nuclei were stained with TOTO-3 iodide (1:500; Life Technologies,
Milan, Italy). Negative controls were obtained by incubating sections with
isotype-matched control antibodies at the same concentration as primary
antibody and/or pre-incubating each antibody with the corresponding control
peptide (final concentration as indicated by manufacture’s instructions). Images
of a number of colon areas, corresponding to the longitudinal smooth muscle
layer (LM), circular smooth muscle layer (CM) and myenteric ganglia (MG), were
acquired with a Nikon C1 confocal microscope. All microscope settings were set
to collect images below saturation and were kept constant for all images. P2X7Rs
or HuC/D immunoreactivities were determined by measuring the area (number
of pixels) and fluorescent intensity (average intensity of pixels) of staining from 24
images captured randomly in the colonic neuromuscular compartment from each
control and inflamed tissue samples. Simultaneously, the mean intensities of P2X7
receptors or HuC/D signals were normalized to mean TOTO-3 intensities for each
neurons. Fluorescence values were expressed as mean values in arbitrary
fluorescence units (A.U.). Image analysis and quantification of the fluorescence
intensity were performed using ImageJ software (version 1.48a).
Recording of contractile activity
Animals were sacrificed by cervical dislocation, the abdomen was immediately
opened, and the colon was removed and placed in Krebs solution. Colonic
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longitudinal smooth muscle preparations, of approximately 3-mm width and 20-
mm length, were set up in organ baths containing Krebs solution, at 37 C˚,
bubbled with 95% O2+5% CO2. The colonic strips were oriented along the
longitudinal axis, and connected to isometric force transducers (2Biological
Instruments, Besozzo, VA, Italy). A tension of 1.0 g was slowly applied to these
tissues. Mechanical activity was recorded by BIOPAC MP150 (2Biological
Instruments, Besozzo, VA, Italy).
Krebs solution had the following composition (mM): NaCl 113, KCl 4.7, CaCl2
2.5, KH2PO4 1.2, MgSO4 1.2, NaHCO3 25, glucose 11.5 (pH 7.4¡0.1). Each
colonic preparation was allowed to equilibrate for at least 30 min, with
intervening washings at 10-min intervals. A pair of coaxial platinum electrodes
was positioned at a distance of 10 mm from the longitudinal axis of each
preparation to deliver transmural electrical stimulation (ES) by a BM-ST6
stimulator (Biomedica Mangoni, Pisa, Italy). Electrical stimuli were applied as
follows: i) 10-s single trains (sES), consisting of square wave pulses (0.5 ms, 30
mA, 10 Hz); ii) recurrent trains (rES) of square wave pulses (0.5 ms, 30 mA,
10 Hz) applied for 5 s every 60 s. In addition, we performed a set of experiments
using stimulation with a submaximal concentration (1 mM) of carbachol in the
presence of tetrodotoxin.
Design of experiments
In the first set of experiments, the effects of N-cyano-N’’-[(1S)-1-phenylethyl]-N’-
5-quinolinyl-guanidine (A804598, P2X7 receptor antagonist, 0.001–100 mM) were
assayed on sES-induced motor responses of colonic preparations maintained in
standard Krebs solution.
In the second set of experiments, A804598 (0.1 mM) was tested, in the presence
of apyrase (the enzyme responsible for ATP catabolism, 10 U/ml) on colonic
contractions evoked by electrical stimuli, in order to provide in our model a direct
evidence that P2X7 recptors are tonically achieved by endogenous ATP.
In the third series of experiments, the effects of A804598 (0.1 mM) were tested
on sES-evoked contractions in colonic preparations maintained in Krebs solution
containing guanethidine (adrenergic blocker, 10 mM), L-732,138 (NK1 receptor
antagonist, 10 mM), GR-159897 (NK2 receptor antagonist 1 mM) and SB-218795
(NK3 receptor antagonist, 1 mM), in order to prevent activation of adrenergic and
tachykinergic pathways.
The fourth set of experiments was designed to assay the effects of A804598
(0.1 mM) on contractile responses elicited by sES directed mainly to excitatory
cholinergic nerves. Therefore, to prevent non-cholinergic motor responses,
colonic preparations were maintained in Krebs solution containing guanethidine,
L-732,138, GR-159897, SB-218795 and Nv-propyl-L-arginine (NPA; 0.01 mM), a
selective inhibitor of neuronal nitric oxide synthase (nNOS).
In the fifth series, A804598 (0.001–100 mM) was assayed on cholinergic
contractions elicited by direct pharmacological activation of muscarinic receptors
located on smooth muscle cells. For this purpose, colonic preparations were
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maintained in Krebs solution containing tetrodotoxin (1 mM) and stimulated
with carbachol (1 mM).
In the sixth series of experiments, the effects of 29(39)-O-(4-benzoylbenzoy-
l)adenosine-59-triphosphate (BzATP, P2X7 receptor agonist; 0.01–100 mM) was
tested on rES-induced contractions in the absence or in the presence of A804598
(0.1 mM).
The last set of experiments was performed to evaluate the effects of BzATP
(0.01–100 mM) on cholinergic contractions elicited by carbachol (1 mM). For this
purpose, colonic tissues were maintained in Krebs solution containing
tetrodotoxin (1 mM).
The effects of test drugs were expressed as percent changes of control
contractions elicited by ES or carbachol. The apparent potency of the P2X7
receptor agonist was expressed as EC50 (concentration of the agonist that
produces 50% of its own maximal response). The percent maximum inhibition of
control motor responses (Emax) was also estimated. Both parameters were
calculated from concentration-response curves and then averaged.
Evaluation of ATP release
The evaluation of ATP release was performed as previously reported by Vieira et
al. [15]. Briefly, the experiments were performed in organ baths containing
standard Krebs solution at 37 C˚, bubbled with 95% O2+5% CO2 in the absence or
in the presence of apyrase (10 U/ml) [16]. Longitudinal muscle preparations were
allowed to equilibrate in the medium for at least 30 min, with intervening
washings at 10-min intervals. Following the equilibration period, colonic tissues
were electrically stimulated using 10-s single trains (sES), consisting of square
wave pulses (0.5 ms, 30 mA, 10 Hz). Before and after each electrical stimulation,
200 ml aliquots of incubation medium were collected, frozen in liquid nitrogen
and stored at 220 C˚. ATP was assayed by means of a luciferine-luciferase ATP
Determination Kit (Roche Diagnostics Mannheim, Germany), and luminescence
was determined by means of a multidetection microplate reader. The release of
ATP was calculated by subtracting the basal release, measured in the medium
sample collected before electrical stimulation, from the total release of adenine
nucleotides, as determined after stimulation.
Drugs and reagents
Atropine sulphate, guanethidine monosulphate, carbachol chloride, 2,4-dinitro-
benzenesulfonic acid (DNBS), apyrase, were purchased from Sigma Chemicals Co.
(St. Louis, Mo, USA). Tetrodotoxin, N-acetyl-L-tryptophan 3,5-bis(trifluoro-
methyl)benzyl ester (L-732,138), 5-fluoro-3-[2-[4-methoxy-4-[[(R)-phenylsul-
phinyl]methyl]-1-piperidinyl]ethyl]-1H-indole (GR-159897), (R)-[[2-phenyl-4-
quinolinyl)carbonyl]amino]-methyl ester benzeneacetic acid (SB-218795), and
Nv-propyl-L-arginine (NPA) were obtained from Tocris (Bristol, UK). Isoflurane
was purchased from Abbott (Roma, Italy). Random hexamers, Moloney murine
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leukaemia virus (MMLV)-reverse transcriptase, Taq polymerase and dNTP
mixture, dithiothreitol were purchased from Promega (Madison, WI). P2X7
receptor ligands were dissolved in dimethyl sulphoxide, and further dilutions were
made with saline solution. Dimethyl sulphoxide concentration in organ bath
never exceed 0.5%.
Statistical Analysis
Data are expressed as mean¡SEM. The significance of differences was evaluated
on raw data, before percentage normalization, by performing unpaired Student’s
t-tests or by one-way ANOVA followed by post hoc Dunnett’s test. P,0.05 was
considered significant. Colonic preparations included in each test group were
obtained from distinct animals, and therefore the number of experiments refers
also to the number of animals assigned to each group. Calculations and analyses
were performed using GraphPad Prism 3.0 (San Diego, CA-USA).
Results
Assessment of colitis
At day 6 after treatment with DNBS, the distal colon appeared thickened and
ulcerated with evident regions of transmural inflammation. Adhesions were often
present and the bowel was occasionally dilated. Colitis was characterized by an
intense granulocyte infiltrate extending throughout the mucosa and submucosa,
sometimes involving the muscular layer. An increase in both macroscopic and
microscopic damage score was observed (1.2¡0.8 and 1. 5¡0.6 in normal rats;
12¡3 and 9¡1.5 in DNBS-treated animals, respectively (P,0.05 vs normal rats).
The immunohistochemical analysis of colonic muscularis externa identified the
presence of both CD68+ macrophages and tryptase+ mast cells dispersed in the
muscular layers and myenteric ganglia of colonic sections from DNBS-treated rats
(S1 Fig.).
Immunofluorescence
In the colon of control animals, the immunohistochemical analysis revealed
homogenous bundles of HuC/D+ neurons with associated GFAP+ glial cells,
aggregated in well-organized and detectable myenteric ganglia (Figs. 1A and 2A,
and S2 Fig.). Double-label immunofluorescence of normal colon showed P2X7
receptors mainly localized in HuC/D+ neurons, but not in GFAP+ glial cells of the
myenteric ganglia (Figs. 1A and 2A, and S2 Fig.).
The induction of colitis altered the architecture of the enteric nervous system
(ENS), determining loosely packed HuC/D+ neurons, associated with apparent
variations of their cell body shape, but not of their fluorescence intensity, and
dispersed clusters of GFAP+ glia showing distorted cellular processes (Figs. 1B and
2B, and S2 Fig.). In the presence of colitis, a rearrangement of P2X7 receptor
distribution was observed in the neuromuscular layer of inflamed animals, with
P2X7 Receptors and Colonic Motor Dysfunction
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increased staining in myenteric ganglia, mainly at the level of longitudinal smooth
muscle layer, whereas it was scanty in the circular muscle layer, as revealed by the
analysis of fluorescence intensity (Fig. 3).
Contractile activity of colonic longitudinal smooth muscle
During equilibration in standard Krebs solution, some colonic preparations
developed spontaneous contractile activity, which remained stable throughout the
experiment and, in most cases, was low in amplitude and did not interfere with
motor responses evoked by ES or carbachol. The development of spontaneous
motor activity was observed with similar frequency and amplitude in preparations
from normal or inflamed colon. Electrically evoked responses consisted of phasic
contractions followed, in some cases, by after-contractions of variable amplitude.
Atropine (1 mM) abolished these phasic contractions, or converted them into
relaxations, and only after-contractions became evident (not shown; n58).
Tetrodotoxin (1 mM) abolished the electrically induced contractions (not shown;
n58).
Fig. 1. Double-staining immunohistochemistry showing the distribution of P2X7 receptors (green) and
the neuronal marker HuC/D (red) in the myenteric plexus of colonic cryosections from control (A;
normal) or DNBS-treated (B; colitis) rats. Nuclei were stained with TOTO-3. Scale bar: 21 mm. Enlarged
view of HuC/D+ and P2X7+ cells in the myenteric ganglia of normal and colitis rats from boxed area in overlay
(scale bar510 mm). LM, longitudinal muscle; CM, circular muscle; MG, myenteric ganglia. Isotype fluorescent
image was obtained by labeling with streptavidin conjugated with Alexa Fluor 555 in presence of normal
mouse antiserum instead of the primary antibody.
doi:10.1371/journal.pone.0116253.g001
P2X7 Receptors and Colonic Motor Dysfunction
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Fig. 2. Double immunostaining showing the expression of P2X7 receptors (green) and the glial marker
GFAP (red) in myenteric plexus of colonic cryosections from control (A; normal) and DNBS-treated (B;
colitis) rats. Nuclei were stained with TOTO-3. Scale bar: 21 mm. Enlarged view of GFAP+ and P2X7+ cells in
the myenteric ganglia of normal and colitis rats from boxed area in overlay (scale bar510 mm). LM,
longitudinal muscle; CM, circular muscle; MG, myenteric ganglia. Isotype fluorescent image was obtained by
labeling with Alexa Fluor 555 conjugated secondary antibody in presence of normal mouse antiserum instead
of the primary antibody.
doi:10.1371/journal.pone.0116253.g002
Fig. 3. Levels of fluorescence intensity of HuC/D+ neurons (A) or P2X7 receptors+ cells (B), expressed
as arbitrary units (AU), in the myenteric ganglia or the colonic neuromuscular layer (MG, myenteric
ganglia; LM, longitudinal muscle; CM, circular muscle), either in the absence (normal) or in the
presence of colitis, respectively. *P,0.01 versus colitis.
doi:10.1371/journal.pone.0116253.g003
P2X7 Receptors and Colonic Motor Dysfunction
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Effects of P2X7 receptor blockade
Under resting conditions, the P2X7 receptor antagonist A804598 did not affect the
spontaneous contractile activity of normal or inflamed colonic preparations (not
shown). In normal colonic tissues, maintained in standard Krebs solution,
A804598 (0.001–10 mM) did not affect sES-evoked contractions (+7.8¡3.4% at
0.1 mM) (Fig. 4A), while in the presence of colitis, it induced a significant increase
in sES-evoked motor responses, with a maximal effect occurring at 0.1 mM
(+42.5¡3.8%) (Fig. 4B). However, the blunting effects observed with A804598
(1–10 mM) could be ascribed to actions putatively unrelated to P2X7 receptor
blockade, resulting from a loss of selectivity at high concentrations. In the
presence of apyrase, the enhancing effect of A804598 (0.1 mM) no longer occurred
(Fig. 5).
In colonic tissues incubated in Krebs solution containing guanethidine, L-
732.138 (NK1 receptor antagonists, 10 mM) GR159897 (NK2 receptor antagonists,
1 mM), and SB218795 (NK3 receptor antagonists, 1 mM), sES elicited phasic
contractions which were prevented by atropine and, in most cases, were converted
into NPA-sensitive relaxations (not shown). Under these experimental conditions,
the effects of A804598 (0.1 mM) on sES-induced contractions, in both normal and
inflamed colonic tissues, were similar to those recorded in the presence of
standard Krebs (normal tissues: +9.4¡2.8%; inflamed tissues: +48¡4%).
When colonic preparations were maintained in Krebs solution added with
guanethidine (10 mM), NPA (inhibitor of nNOS, 0.01 mM) and NK receptor
antagonists, the application of sES elicited phasic cholinergic contractions, which
were largely abolished by atropine (not shown; n58). Under these conditions,
A804598 (0.1 mM) was without significant effects both in the absence and in the
presence of colonic inflammation (Fig. 6A).
In a set of experiments, the effects of P2X7 blockade were tested on contractions
evoked by direct activation of muscarinic receptors on longitudinal smooth
muscle. For this purpose, the effects of A804598 were evaluated on contractions
elicited by carbachol (1 mM) in the presence of tetrodotoxin (1 mM). In this
setting, carbachol-induced colonic contractions were not significantly affected by
A804598 both in the absence or in the presence of colitis (Fig. 6B).
Effects of P2X7 receptor activation
The effects of increasing concentrations of the P2X7 receptor agonist BzATP
(0.0001–10 mM) were tested on rES-induced contractions in normal and inflamed
colonic preparations maintained in Krebs solution containing guanethidine and
NK receptor antagonists. Under these conditions, BzATP induced a concentra-
tion-dependent relaxant response in normal tissues (EC50523.1¡3.6 nM;
Emax5–15.2¡0.8%) (Fig. 7A), with higher efficacy in preparations from inflamed
colon (EC50526.3¡3.6 nM; Emax5–25.5¡2.4%) (Fig. 7A). The inhibitory effects
of BzATP were antagonized by A804598 (0.1 mM) both in normal and inflamed
colonic tissues (Fig. 7B).
P2X7 Receptors and Colonic Motor Dysfunction
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In the presence of tetrodotoxin (1 mM), contractions elicited by carbachol
(1 mM) were not affected by BzATP (1 mM) in colonic preparations obtained
either normal or inflamed animals (Fig. 8).
Release of ATP
Extracellular ATP concentration (pmol/mg tissue) was evaluated by means of
bioluminescence assay, in aliquots of medium collected both before and after
electrical stimulation of colonic longitudinal muscles preparations from control
and DNBS-treated rats. A significant increase in ATP levels was observed in
medium samples collected from preparation of inflamed colonic, under basal
condition as compared to control (Fig. 9). Likewise, ATP levels were significantly
increased after electrical stimulation in the aliquots harvested from inflamed
tissues, as compared with control specimens (Fig. 9).
Fig. 4. Preparations of longitudinal smooth muscle isolated from normal (A) or DNBS-treated rats
(colitis) (B). Effects of increasing concentrations of A804598 (0.001–10 mM) on contractions evoked by sES
(0.5 ms, 10 Hz, 30 mA, 10 s) in preparations maintained in standard Krebs solution. Each column represents
the mean¡SEM obtained from 6 experiments. *P,0.05, versus control (CON).
doi:10.1371/journal.pone.0116253.g004
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Discussion
In recent years, an increasing interest has been focused on the involvement of
P2X7 receptors in the pathophysiology of IBDs, where these receptors play a
pivotal role in orchestrating immune cell activity as well as in regulating the
neurodegenerative processes associated with gut inflammation [7, 11, 17]. Despite
a physiological expression of P2X7 receptors throughout the murine
[10, 11, 18, 19] or human [11] gut has been documented, data concerning the
possible rearrangement and influence of these receptors on enteric dysmotility in
the presence of bowel inflammation are scanty.
The present study was carried out to determine the localization of P2X7
receptors in the neuromuscular compartment of rat distal colon, as well as to
characterize the possible involvement of these receptors in colonic motor
disorders associated with experimental colitis. Particular care was taken to
highlight the influence exerted by P2X7 receptors on the regulatory pathways of
colonic neuromotility following the induction of bowel inflammation. Our
findings provide evidence that: a) under normal conditions, P2X7 receptors,
expressed in myenteric ganglia, take a minor part in a tonic inhibitory control on
excitatory cholinergic motility, acting at neuronal level; b) the induction of
colonic inflammation is associated with an increase in extracellular ATP
concentrations; c) in the presence of bowel inflammation, a marked increase in
P2X7 receptor immunostaining, and an enhanced modulating action of these
receptors on colonic neuromotility become evident.
Under normal conditions, our immunofluorescence investigations displayed an
appreciable neural localization of P2X7 receptors in the myenteric plexus. These
findings are consistent with immunoreactivity for P2X7 receptors described
previously throughout the myenteric plexus in guinea pigs [20], mice [11], rats
[10, 18, 19] and humans [11]. We then performed functional investigations to
Fig. 5. Effects of A804598 (0.01mM) on contractions evoked by sES (0.5 ms, 10 Hz, 30 mA, 10 s) in
colonic longitudinal muscle preparations maintained in Krebs solution added with apyrase (10 U/ml).
Each column represents the mean¡SEM obtained from 6 experiments. *P,0.05, versus control.
doi:10.1371/journal.pone.0116253.g005
P2X7 Receptors and Colonic Motor Dysfunction
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Fig. 6. (A) Effects of A804598 (0.01 mM) on cholinergic contractions evoked by sES (0.5 ms, 10 Hz, 30 mA,
10 s) in colonic preparations isolated from normal or inflamed rats (colitis), maintained in Krebs solution
containing guanethidine (10 mM), L-732 138 (10 mM), GR-159897 (1 mM), SB-218795 (1 mM) and NPA
(0.01 mM). (B) Column graphs showing the effects of A804598 (0.01 mM) on contractions evoked by
carbachol (1 mM) in colonic preparations isolated from normal or inflamed rats (colitis) and maintained in
Krebs solution containing tetrodotoxin (1 mM). Each column represents the mean¡SEM value obtained from
6 experiments. CARB, carbachol. Each column represents the mean¡SEM obtained from 6 experiments.
*P,0.05, versus control.
doi:10.1371/journal.pone.0116253.g006
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determine the enteric neuromotor pathways regulated by P2X7 receptors. Our
experiments showed that the P2X7 receptor antagonist scarcely affected the
electrically-induced contractions of colonic longitudinal smooth muscle. In
addition, upon incubation with the P2X7 receptor agonist, a slight concentration-
dependent decrease in the amplitude of motor responses to electrical stimuli was
observed. This effect was reversed by the P2X7 receptor antagonist. It was then
considered that P2X7 receptor ligands might affect the evoked contractions of rat
colon at neuronal and/or muscular sites, and therefore their effects were tested in
the presence of a direct stimulation of colonic smooth muscle by carbachol. In this
setting, the contractile responses of normal preparations were not modified by
P2X7 receptor activation or blockade, thus indicating that this receptor does not
operate at muscular sites to control the colonic neuromuscular functions. Taken
together, these observations support the concept that, under normal conditions,
Fig. 7. (A) Effects of increasing concentrations of BzATP (0.001–100 mM) on contractions evoked by rES
(0.5 ms, 30 mA, 10 Hz, 5 s every 60 s) in colonic preparations maintained in Krebs solution containing
guanethidine and NK receptor antagonists. (B) Column graphs showing the effects of BzATP (1 mM) on
contractions evoked by sES (0.5 ms, 30 mA, 10 Hz), alone and in combination with A804598 (0.1 mM), in
colonic preparations maintained in Krebs solution containing guanethidine and NK receptor antagonists. Each
point represents the mean¡SEM of eight experiments. *P,0.05, versus control.
doi:10.1371/journal.pone.0116253.g007
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P2X7 receptors are marginally involved in the modulation of rat colonic
longitudinal muscle motility.
Increasing evidence highlights a critical role of ATP in the pathophysiology of
inflammation [21]. In this context, special attention is being paid to the role
played by P2X7 receptors in the regulation of inflammatory responses. Indeed,
P2X7 receptor ligands have been tested, with encouraging results, in preclinical
models of inflammation (chronic pulmonary diseases, glomerulonephritis,
rheumatoid arthritis, multiple sclerosis) [22]. For this reason, the P2X7 receptor is
currently viewed as an intriguing target for the development of novel therapeutic
tools, as testified by a number of clinical phase I and II trials aimed at evaluating
the efficacy of P2X7 receptor antagonists on several inflammatory conditions [22].
Several lines of evidence indicate the pharmacological modulation of purinergic
receptors as a viable way to curb intestinal inflammation [4]. In particular,
Marques et al. [23] demonstrated the efficacy of P2X7 receptor blockade in
preventing experimental colitis, and decreasing the density of immune/in
flammatory cells in the lamina propria [23]. However, a paucity of information is
Fig. 8. Column graphs showing the effects of BzATP (1 mM) on contractions evoked by carbachol
(1 mM) in colonic preparations obtained from normal or inflamed rats (colitis) maintained in Krebs
solution containing tetrodotoxin (1 mM). Each column represents the mean¡SEM value obtained from
eight experiments. CARB, carbachol.
doi:10.1371/journal.pone.0116253.g008
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available about the possible significance of P2X7 receptors in the alterations of
enteric neuromuscular functions associated with bowel inflammation. In order to
address this issue, the second part of this study was aimed at clarifying the role of
P2X7 receptors in the colonic neuromuscular activity in the presence of colitis.
Our immunofluorescent analysis revealed a marked increment of P2X7 receptor
distribution, particularly at level of myenteric ganglia, which occurred in
concomitance with the appearance of receptor immunopositivity also in the
longitudinal muscle. These findings are in keeping with recent data displaying an
increase in P2X7 receptor expression in murine models of colitis [17, 23, 24] as
well as in specimens of intestinal mucosa from patients with IBDs [24].
The above morphologic data are consistent with the results of our functional
experiments on inflamed colon. Indeed, the blockade of P2X7 receptors elicited a
more pronounced enhancing effect on electrically induced contractions, as
compared to normal conditions. Of note, these enhancing effects were also
appreciable after blockade of noradrenergic and tachykininergic pathways, while
they were blunted upon incubation of inflamed colonic preparations with a
neuronal nitric oxide synthase (NOS) inhibitor. Moreover, despite our
immunofluorescence analysis revealed an induction of P2X7 receptors in the
longitudinal muscular layer of inflamed colon, no significant effects were recorded
when testing P2X7 receptor ligands on carbachol-induced cholinergic contrac-
tions. Taken together, these observations support the view that, in the presence of
bowel inflammation, P2X7 receptors take a prominent part in the inhibitory
control of rat colonic motility, modulating the cholinergic excitatory pathways
through activation of inhibitory nitrergic neurons. Consistently with this
proposal, a colocalization of P2X7 receptors with NOS was previously described
Fig. 9. Effect of electrical field stimulation (EFS) on extracellular levels of ATP, expressed in pmol/mg
of tissue, immediately before (basal) and after (post-ES) electrical stimulation of colonic longitudinal
muscle preparations obtained from normal and inflamed rats. Each column represents the mean¡SEM
value obtained from 8 experiments. *P,0.05, versus control (CON).
doi:10.1371/journal.pone.0116253.g009
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by Hu et al. [20] in the myenteric plexus of guinea-pig ileum. In the same study,
electrophysiological experiments revealed that the pharmacological stimulation of
P2X7 receptors evoked depolarizing responses, thus supporting a modulatory role
of these receptors on nitrergic neurotransmission [20]. In this context, the
functional significance of the up-regulation of P2X7 receptors in the smooth
muscle layers of inflamed colon remains undetermined. However, we cannot rule
out the possibility that the P2X7 receptor induction in the muscular compartment
of inflamed colon might fulfill regulatory activities unrelated to the cholinergic
pathway or linked to other inflammatory mechanisms unrelated with enteric
motor functions. To the best of our knowledge, this is the first study providing a
functional characterization of P2X7 receptors in the rat colonic neuromuscular
compartment in the presence of colitis. Some lines of evidence concur with the
present results to suggest the involvement of P2X7 receptors in the inflammation-
associated colonic motor dysfunction. In particular, Gulbransen et al. [11]
described a tight interplay between P2X7 receptors and pannexin-1 in mediating
enteric neuronal death associated with experimental colitis.
The net cellular response to purinergic stimulation is known to depend on the
availability of ATP in the extracellular environment [4]. Virtually all cell types (i.e.
neurons, muscular and immune cells), act as sources of extracellular ATP, via
either lytic or non-lytic mechanisms (i.e exocytosis of ATP-containing vesicles,
nucleotide-permeable channels, transport vesicles, and via lysosome) [4].
However, under inflammatory conditions, activated immune cells represent a
relevant source of ATP [25]. In particular, this nucleotide, once released from
injured and inflammatory cells through pannexin hemichannels (i.e. pannexin-1),
has been shown to interact with P2X7 receptors expressed on immune cells and to
activate further inflammary cells that migrate to the site of injury [26]. Based on
these evidences, it is not surprising that the inflammatory microenvironment is
very rich in extracellular ATP [27] particularly in close proximity of P2X7
receptors, which are known to be molecularly linked to pannexin channels [11].
In this regard, our immunofluorescence analysis confirmed the presence of
infiltration by CD68+ macrophages and trypatse+ mast cells in the colonic
neuromuscular layer of DNBS-treated rats. These findings are in line with data by
Shi et al. [28], who examined the progression of TNBS–induced inflammation in
colonic sections, showing a significant increase of activated macrophages in the
mucosa/submucosa and muscularis externa. In line with the concept of an
enhancement of extracellular ATP during inflammation [29], we observed also
increased concentrations of ATP in the incubation media of colonic preparations
from DNBS-treated rats both under resting conditions and after electrical
stimulation. Consistently with the results by Vieira et al. [15], our ATP levels were
in the range of picomolar concentration. Even though P2X7 receptors require
micromolar concentrations of ATP to be activated, current knowledge suggests
that ATP levels found in tissue incubation media do not likely reflect the actual
ATP concentrations available for receptor activation in purinergic receptor
biophase [30, 31]. There is indeed growing evidence supporting the view that,
through complex interplays between different enzymes and transporters, very
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different levels of purinergic mediator can be maintained in the biophase of a
given receptor, under different physiologic or pathologic conditions, with highly
variable biologic consequences, ranging from a complete prevention of receptor
activation to a highly amplified receptor stimulation. Thus, according to the novel
concept of ‘‘purinome’’[30], the concentration of purinergic transmitter in close
proximity of a given purinergic receptor can be widely regulated to achieve low or
high degrees of receptor activation, without apparent substantial changes of
transmitter levels more abroad (i.e in the overall compartment of extracellular
fluids).
In conclusion, the present study highlights a novel and intriguing role of P2X7
receptors in the regulation of colonic neuromuscular functions, both under
normal conditions and, to a greater extent, in the presence of bowel inflammation.
These observations, together with increasing knowledge about the immunomo-
dulatory/anti-inflammatory effects resulting from P2X7 receptor modulation,
might provide a promising basis for the development of novel pharmacological
tools [28], potentially useful for the therapeutic management of enteric
dysmotility associated with bowel inflammation. In particular, the pharmacolo-
gical blockade of P2X7 receptors by selective antagonists could represent a suitable
way to counteract inflammatory processes as well as for the management of those
phases of IBD characterized by reduced bowel motor activity and constipation.
Supporting Information
S1 Fig. Dual-label immunohistochemistry showing the distribution of HuC/D+
neurons (panels A and B), CD68+ macrophages (panel A) and tryptase+
mastcells (panel B) in the myenteric plexus of colonic cryosections from
control (normal) or DNBS-treated (colitis) rats. Scale bar521 mm. Isotype
fluorescent image was obtained by dual labeling with Alexa Fluor 488 conjugated
secondary antibody and streptavidin conjugated with Alexa Fluor 555 in presence
of normal mouse antiserum instead of the primary antibodies (panel C).
doi:10.1371/journal.pone.0116253.s001 (TIF)
S2 Fig. Representative image showing that preabsorption of anti-P2X7
antibody with immunogenic peptide for P2X7 totally blocks P2X7 immunor-
eactivity without affecting HuC/D or GFAP immunoreactivity in the myenteric
plexus of colonic cryosections from control rats. Scale bar521 mm.
doi:10.1371/journal.pone.0116253.s002 (TIF)
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